FDA May Require Label Changes For All Alpha-1 Blockers
This article was originally published in The Pink Sheet Daily
Executive Summary
Intraoperative floppy iris syndrome may be associated with alpha-1 blockers such as Boehringer Ingelheim’s Flomax.